SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will report its financial results for the fourth quarter and year ended December 31, 2010 on Thursday, March 10, 2011, after the U.S. financial markets close. ACADIA's management will host a conference call and webcast on Thursday, March 10, 2011, at 5:00 p.m. Eastern Time to discuss ACADIA’s financial results and development programs.
